Publications by authors named "Manuel Benavides"

Claim this Profile
E
Environmental risk management: A participatory diagnosis from a rural school in Colombia.
Carolina Moncayo, Christian Benitez, Víctor Quintero, Carolina González, Jorge Muñoz, Manuel Benavides

Jamba· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial).
Guillem Argilés, Nuria Mulet, Manuel Valladares-Ayerbes, José M Viéitez, Cristina Grávalos, Manuel Benavides

Eur J Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Super-resolution microscopy for the study of store-operated calcium entry.
Carlos Bastian, Alicia Sampieri, Manuel Ortínez Benavides, Adán Guerrero, Luis Vaca

Cell Calcium· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
Manuel Benavides, Auxiliadora Gómez-España, Pilar García-Alfonso, Cristina García González, Jose María Viéitez

Eur J Surg Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.
Luis A Diaz, Kai-Keen Shiu, Tae-Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, Manuel Benavides

Lancet Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceleration of the DNA methylation clock among lynch syndrome-associated mutation carriers.
Marta Cuadros, Carlos Cano, Sonia Garcia-Rodriguez, José Luis Martín, Antonio Poyatos-Andujar, Manuel Benavides

BMC Med Genomics· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study.
Elisa Conde, Julie Earl, Lorena Crespo-Toro, Carolina Blanco-Agudo, Edurne Ramos-Muñoz, Manuel Benavides

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
Thierry André, Kai-Keen Shiu, Tae Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, Manuel Benavides

N Engl J Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of sequential treatment of nab-paclitaxel in combination with gemcitabine followed by modified FOLFOX chemotherapy in patients with untreated metastatic exocrine pancreatic cancer: Phase I results.
Alfredo Carrato, José María Vieitez, Manuel Benavides, Mercedes Rodriguez-Garrote, Alfredo Castillo

Eur J Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO).
Juan Manuel Sepúlveda-Sánchez, Miguel Gil-Gil, Miriam Alonso-García, María Ángeles Vaz Salgado, Elena Vicente, Manuel Benavides

Target Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Options for Third-line and Beyond Treatment of Metastatic Colorectal Cancer. Spanish TTD Group Expert Opinion.
Ana Fernández-Montes, Cristina Grávalos, Carles Pericay, Ma José Safont, Manuel Benavides

Clin Colorectal Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour location and efficacy of first-line EGFR inhibitors in wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials.
Manuel Benavides, Eduardo Díaz-Rubio, Alfredo Carrato, Albert Abad, Carmen Guillén

ESMO Open· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel.
Jason Willis, Martina I Lefterova, Alexander Artyomenko, Pashtoon Murtaza Kasi, Yoshiaki Nakamura, Manuel Benavides

Clin Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples.
Ana Vivancos, Enrique Aranda, Manuel Benavides, Elena Élez, Maria Auxiliadora Gómez-España

Sci Rep· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Morphological MRI-based features provide pretreatment survival prediction in glioblastoma.
Julián Pérez-Beteta, David Molina-García, Alicia Martínez-González, Araceli Henares-Molina, Mariano Amo-Salas, Manuel Benavides

Eur Radiol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphological MRI-based features provide pretreatment survival prediction in glioblastoma.
Julián Pérez-Beteta, David Molina-García, Alicia Martínez-González, Araceli Henares-Molina, Mariano Amo-Salas, Manuel Benavides

Eur Radiol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: Results of the PANOVA phase 2 study.
Fernando Rivera, Manuel Benavides, Javier Gallego, Carmen Guillen-Ponce, José Lopez-Martin

Pancreatology· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer.
Jesús García-Foncillas, Josep Tabernero, Elena Élez, Enrique Aranda, Manuel Benavides

Br J Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).
Pilar García-Alfonso, Manuel Benavides, Esther Falcó, Andrés Muñoz, Auxiliadora Gómez

Oncologist· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers.
Antonio Irigoyen, Cristina Jimenez-Luna, Manuel Benavides, Octavio Caba, Javier Gallego

PLoS One· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Surface Regularity at MR Imaging Predicts Survival and Response to Surgery in Patients with Glioblastoma.
Julián Pérez-Beteta, David Molina-García, José A Ortiz-Alhambra, Antonio Fernández-Romero, Belén Luque, Manuel Benavides

Radiology· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer.
Eric Van Cutsem, Robert J Mayer, Stéphanie Laurent, Robert Winkler, Cristina Grávalos, Manuel Benavides

Eur J Cancer· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.
Juan Manuel Sepúlveda-Sánchez, María Ángeles Vaz, Carmen Balañá, Miguel Gil-Gil, Gaspar Reynés, Manuel Benavides

Neuro Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group.
Antonio Irigoyen, Javier Gallego, Carmen Guillén Ponce, Ruth Vera, Vega Iranzo, Manuel Benavides

Eur J Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients.
Octavio Caba, Antonio Irigoyen, Cristina Jimenez-Luna, Manuel Benavides, Francisco M Ortuño

Toxicol Appl Pharmacol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis